ArrayExpress Gene Expression Atlas home | about the project | faq | feedback | blog | das | api new | help
SEMA3F Homo sapiens
SEMA3F is differentially expressed in 129 experiments [154 up/137 dn]: 42 organism parts: peripheral blood [1 up/1 dn], skeletal muscle [1 up/1 dn], ...; 26 disease states: normal [7 up/3 dn], breast carcinoma [1 up/1 dn], ...; 33 cell types, 34 cell lines, 27 compound treatments and 19 other conditions.
Synonyms SEMA3F
Orthologs Sema3f (Mus musculus)  NP_001101655.1 (Rattus norvegicus)  (Compare orthologs)
InterPro Term Immunoglobulin subtype, Immunoglobulin-like, Immunoglobulin-like fold, Plexin/semaphorin/integrin, WD40/YVTN repeat-like-containing domain
GO Terms extracellular space, membrane, multicellular organismal development, receptor activity
Uniprot Q13275  Q59G50 
Search EB-eye ENSG00000001617
REST API
Expression Summary
244 factor values, click each to filter
Factor Value Factor Up/Down
Legend: - number of studies the gene is up/down in
Normal Disease state
3
7
Stromal cell Cell type
3
2
None Compound treatment
2
1
Homo sapiens Organism
3
HeLa Cell line
2
1
Epithelial cell Cell type
2
1
SW480 Cell line
2
SW620 Cell line
2
Fibroblast Cell type
2
Endothelial cell Cell type
2
FLAP Compound treatment
2
Invasive ductal carcinoma Histology
2
0 cm away from the tumor bound... Observation
2
HNRPA2B Compound treatment
2
MK886 Compound treatment
2
Not applicable Histology
1
1
Breast carcinoma Disease state
1
1
N/a Test result
1
1
Peripheral blood Organism part
1
1
Skeletal muscle Organism part
1
1
Lymph node Organism part
2
Dimethyl sulfoxide Compound treatment
1
1
Bone marrow Organism part
2
Pancreas Organism part
2
Macrophage Cell type
2
Estrogen receptor 1 positive; ... Test result
2
HL-60 Cell line
1
1
Dendritic cell Cell type
2
BT-474 Cell line
1
1
Pan troglodytes Organism
1
1
Primary Disease staging
1
1
Uninfected Infection
1
1
White blood cells Organism part
1
MCF7 Cell line
1
SKMEL5 Cell line
1
PC3 Cell line
1
SsMCF7 Cell line
1
Tumor Organism part
1
Malignant melanoma Disease state
1
Kaposi's sarcoma-associated he... Infection
1
Fetal bovine serum in media Growth condition
1
Organism_part Material type
1
Cell Material type
1
Pretreatment primary sample Clinical info
1
Glucocorticoid sensitive Phenotype
1
Postprandial lipid micelles in... Growth condition
1
ITS medium with albumin-bound ... Growth condition
1
Inter-prandial lipid micelles ... Growth condition
1
ITS medium Growth condition
1
Beas2B Cell line
1
Lymphatic endothelial cell Cell type
1
Glucocorticoid resistant Phenotype
1
Keratinocyte Cell type
1
MDA-MB-231 Cell line
1
Whole blood Organism part
1
Vascular smooth muscle cell Cell type
1
Chondrocyte Cell type
1
Testis Organism part
1
T47D Cell line
1
Rapamycin Compound treatment
1
MCF10A Cell line
1
Idiopathic dilated cardiomyopa... Disease state
1
Cartilage Organism part
1
Seminiferous tubule Organism part
1
Superior cervical ganglion Organism part
1
Spermatid Cell type
1
Spermatocyte Cell type
1
Superficial transitional cell ... Disease state
1
Benign nevi Disease state
1
A549 Cell line
1
SKBR3 Cell line
1
Relapse 1; ER status ER+; brai... Clinical info
1
Control RNAi
1
SIM2s RNAi
1
Smooth muscle Organism part
1
Geriatric Developmental stage
1
Pediatric Developmental stage
1
Serum starvation + thymidine b... Growth condition
1
Serum starvation synchronizati... Growth condition
1
Kidney Organism part
1
Stage I Disease staging
1
Heregulin Compound treatment
1
HPL1 Cell line
1
Trigeminal ganglion Organism part
1
Relapse 0; ER status ER+; brai... Clinical info
1
Atrioventricular node Organism part
1
HaCaT Cell line
1
Epidermal keratinocyte Cell type
1
SkinEthic keratinocyte Cell type
1
None Gene modification
1
4OH-tamoxifen Compound treatment
1
Native skin Cell type
1
T3bN1M0 Disease staging
1
Estrogen receptor 1 negative; ... Test result
1
Cerebellum Organism part
1
PCep4 control vector transfect... Gene modification
1
ETat plasmid transfection Gene modification
1
Baseline uninfected Disease state
1
Macaca mulatta Organism
1
GLI60 Cell line
1
Bacterial endotoxin Compound treatment
1
Control Compound treatment
1
Ischemic cardiomyopathy Disease state
1
Grade IV Tumor grading
1
Atrial mycocardium Organism part
1
Ventricular myocardium Organism part
1
Glioblastoma Disease state
1
Primary lymphatic endothelial ... Cell type
1
Dorsal root ganglion Organism part
1
Ciliary ganglion Organism part
1
T-cell acute lymphoblastic leu... Disease state
1
Synovial fluid Organism part
1
Epidermal growth factor Compound treatment
1
2-(3,4,5-trimethoxy-phenylamin... Compound treatment
1
Chronic lymphocytic leukemia Disease state
1
Methotrexate Compound treatment
1
Acute malaria, natural infecti... Disease state
1
TIVE Cell line
1
Trichostatin A Compound treatment
1
Primary gastric tumor Organism part
1
Unknown_sex Sex
1
HTERT/HPVE6/HPVE7/SV40t/hRas t... Gene modification
1
Tonsil Organism part
1
MS589 Cell line
1
IgV status unknown Genotype
1
Skin substitute Cell type
1
Pons Organism part
1
Cystic change Histology
1
5-aza-2'-deoxycytidine + trich... Compound treatment
1
Normal Histology
1
Carcinoma in situ lesion Disease state
1
GLI72 Cell line
1
T4aN0M0 Disease staging
1
IgV mutated Genotype
1
T1aN0M0 Disease staging
1
Estrogen receptor 1 positive; ... Test result
1
Cadmium chloride 2.5-hydrate Compound treatment
1
Female Sex
1
Estrogen receptor 1 positive; ... Test result
1
Kaposi's sarcoma Disease state
1
Monoclonal gammopathy of undet... Disease state
1
No induction Protocol type
1
Infergen + interferon-gamma Compound treatment
1
T47-D Cell line
1
T-cell lymphoblastic lymphoma Disease state
1
DMSO Vehicle
1
Non-basal-like breast cancer Disease state
1
Primary culture 2 Cell line
1
Capra hircus Organism
1
Osteoblast Cell type
1
Leydig cell Cell type
1
White blood cell Cell type
1
Platelet Cell type
1
Heat-killed HL60 cell lysate Infection
1
Hippocampus Organism part
1
KSHV infection Disease state
1
267B1 Cell line
1
267B1_Ki-ras Cell line
1
Beta cell islets Organism part
1
ERalpha transfected Genotype
1
ERbeta transfected Genotype
1
ITM-ST Cell line
1
Ethanol Vehicle
1
Endometrioid carcinoma Disease state
1
Media only Growth condition
1
Cyclosporin A, mycophenolate m... Clinical treatment
1
Sirolimus, mycophenolate mofet... Clinical treatment
1
Stage II Disease staging
1
Mononuclear cell Cell type
1
Total_RNA Material type
1
Polysome-associated RNA Material type
1
Adipose tissue Organism part
1
Non-ischemic cardiomyopathy Disease state
1
Tongue Organism part
1
Primary bone marrow CD34+ stem... Cell type
1
TaN0M0 Disease staging
1
Lymphoid tissue Organism part
1
Estrogen receptor 1 negative; ... Test result
1
Breast cancer Disease state
1
Cervical cancer Disease state
1
Thymus Organism part
1
Papillary thyroid carcinoma Disease state
1
Johnsen score count 3.2: Serto... Histology
1
Pergolide methanesulfonate Compound treatment
1
Down syndrome Disease state
1
Endothelial cell + pericyte Cell type
1
Met5A Cell line
1
IMP(1,3)A RNAi
1
Thalamus Organism part
1
Crohn's disease Disease state
1
Control for heregulin Compound treatment
1
Alveolar space neutrophil Cell type
1
Lymph node metastasis Disease staging
1
BJAB Cell line
1
Heart Organism part
1
Spleen Organism part
1
Cigarette smoke Growth condition
1
Incubator control Growth condition
1
Primary visual cortex Organism part
1
ITM-E6E7 Cell line
1
Interferon-gamma + lipopolysac... Compound treatment
1
MCF-7 Cell line
1
Monocyte Cell type
1
Empty vector Gene modification
1
HMEC184 Cell line
1
Entorhinal cortex Organism part
1
Globus pallidus Organism part
1
Ovary Organism part
1
M1 macrophage Cell type
1
Placebo Compound treatment
1
Glutamine Compound treatment
1
Term Developmental stage
1
Midgestation Developmental stage
1
Liver Organism part
1
T3aNxMx Disease staging
1
T3aNxM1 Disease staging
1
Adipose-derived stem cell Cell type
1
Placenta Organism part
1
Hypericin incubated, not irrad... Growth condition
1
Hypericin incubated, irradiate... Growth condition
1
Dermal fibroblast Cell type
1
HMT3522S1 Cell line
1
Bis [(+)-tartrato] diantimonat... Compound treatment
1
Psoriatic lesional biopsy Clinical info
1
Uninvolved biopsy Clinical info
1
Benign Disease staging
1
T4aN2M1 Disease staging
1
T84 Cell line
1
Caco-2 Cell line
1
Pan paniscus Organism
1
Astrocyte Cell type
1
Plasma cell Cell type
1
B lymphocyte Cell type
1
5-aza-2'-deoxycytidine Compound treatment
1
Infergen Compound treatment
1
Bronchial epithelial cell Cell type
1
Stroma from endometriotic nodu... Organism part
1
Grade II Tumor grading
1
Estrogen receptor 1 negative; ... Test result
1
Vanadium pentoxide Compound treatment
1
G3 Tumor grading
1
Mannitol Compound treatment
1
Age-related macular degenerati... Disease state
1
Prostate Organism part
1
Expression Profiles
E-AFMX-5: Transcription profiling of human cell lines and tissues (GNF/Novartis)
Experimental Factors
Cell type Organism part Disease state
Show expression profile  /  experiment details

 
E-GEOD-5258: Transcription profiling of human cell lines freely cycling treated with 164 distinct small molecules - Broad Connectivity Map CMAP Set 1
Experimental Factors
Show expression profile  /  experiment details

 
E-MEXP-1014: Transcription profiling of two human colon cancer cell lines treated with n-3 PUFA docosahexaenoic acid for 3 different time points
Experimental Factors
Show expression profile  /  experiment details

 
E-MEXP-2034: Transcription profiling of human primary prostate epithelial and stromal cells exposed to 4-methylsulphinylbutyl and 3-methylsulphinypropyl isothiocyanates
Experimental Factors
Show expression profile  /  experiment details

 
E-GEOD-3189: Transcription profiling of human tissue samples to identify novel genes associated with malignant melanoma but not benign melanocytic lesions
Experimental Factors
Disease state
Show expression profile  /  experiment details

 
Processing time: 0.155 secs.